{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T07:19:53Z","timestamp":1791011993873,"version":"4.1.0"},"reference-count":103,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.jneuroim.2007.03.023","type":"journal-article","created":{"date-parts":[[2007,5,3]],"date-time":"2007-05-03T12:40:15Z","timestamp":1178196015000},"page":"181-192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":99,"title":["Differential neuroimmune markers to the onset of Alzheimer's disease neurodegeneration and dementia: Autoantibodies to A\u03b2(25\u201335) oligomers, S100b and neurotransmitters"],"prefix":"10.1016","volume":"186","author":[{"given":"Marina A.","family":"Gruden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatyana B.","family":"Davidova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mantas","family":"Mali\u0161auskas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D.E.","family":"Sewell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina I.","family":"Voskresenskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Wilhelm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena I.","family":"Elistratova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir V.","family":"Sherstnev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludmilla A.","family":"Morozova-Roche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2007.03.023_bib1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1042\/CS20050161","article-title":"Clinical relevance of the neurotrophins and their receptors","volume":"110","author":"Allen","year":"2006","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.jneuroim.2007.03.023_bib2","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.mehy.2006.02.043","article-title":"Neurotransmitter depletion may be a cause of dementia pathology rather than an effect","volume":"67","author":"Alisky","year":"2006","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.jneuroim.2007.03.023_bib3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0301-0082(02)00079-5","article-title":"Alzheimer disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition and treatment strategies","volume":"68","author":"Auld","year":"2002","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib4","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/78682","article-title":"Peripherally administered antibodies against amyloid \u03b2 peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease","volume":"6","author":"Bard","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib5","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0006-8993(95)00160-R","article-title":"S100 beta protects hippocampal neurons from damage induced by glucose deprivation","volume":"677","author":"Barger","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib6","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/j.1471-4159.2005.03407.x","article-title":"Globular amyloid beta-peptide (1\u201342) oligomer \u2014 a homogeneous and stable neuropathological protein in Alzheimer's disease","volume":"95","author":"Barghorn","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib7","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1001\/archneur.61.3.378","article-title":"Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function","volume":"61","author":"Bennett","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib8","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1096\/fasebj.14.9.1233","article-title":"Fresh and globular amyloid beta protein (1\u201342) induces rapid cellular degeneration: evidence for AbP channel-mediated cellular toxicity","volume":"14","author":"Bhatia","year":"2000","journal-title":"FASEB J."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2165\/00002512-200320020-00002","article-title":"Role of the immune system in the pathogenesis, prevention and treatment of Alzheimer's disease","volume":"20","author":"Blasko","year":"2003","journal-title":"Drugs Aging"},{"issue":"9533","key":"10.1016\/j.jneuroim.2007.03.023_bib10","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","article-title":"Alzheimer's disease","volume":"29, 368","author":"Blennow","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2007.03.023_bib11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejphar.2006.06.023","article-title":"Predicting Alzheimer dementia in mild cognitive impairment patients. Are biomarkers useful?","volume":"545","author":"Borroni","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib12","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nn1372","article-title":"Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function","volume":"8","author":"Cleary","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib14","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/jemt.10302","article-title":"Differential expression of S100 proteins in the developing human hippocampus and temporal cortex","volume":"60","author":"Chan","year":"2003","journal-title":"Microsc. Res. Tech."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib13","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1016\/j.febslet.2005.04.041","article-title":"A\u03b2(31\u201335) and A\u03b2(25\u201335) fragments of amyloid beta-protein induce cellular death through apoptotic signals: role of the redox state of methionine-35","volume":"579","author":"Clementi","year":"2005","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib15","doi-asserted-by":"crossref","first-page":"629","DOI":"10.2174\/156802606776743075","article-title":"The role of MRI and PET\/SPECT in Alzheimer's disease","volume":"6","author":"Coimbra","year":"2006","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib16","doi-asserted-by":"crossref","first-page":"6011","DOI":"10.1523\/JNEUROSCI.1189-06.2006","article-title":"Different conformations of amyloid beta induce neurotoxicity by distinct mechanisms in human cortical neurons","volume":"26","author":"Deshpande","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib17","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1096\/fj.05-3956com","article-title":"Abeta peptide immunization restores blood\u2013brain barrier integrity in Alzheimer disease","volume":"20","author":"Dickstein","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib18","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nn842","article-title":"Immunisation reverses memory deficits without reducing brain a beta burden in an AD model","volume":"5","author":"Dodart","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib19","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.biopsych.2005.06.017","article-title":"Cognitive dysfunction, hippocampal atrophy and glucocorticoid feedback in Alzheimer's disease","volume":"59","author":"Elgh","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jneuroim.2007.03.023_bib20","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u2018Mini-mental state\u2019: a practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib21","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/jnr.20870","article-title":"Comparative study of microglia activation induced by amyloid-beta and prion peptides: role in neurodegeneration","volume":"84","author":"Garcao","year":"2006","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib22","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000079197","article-title":"Autoimmune response to the amyloid structures of A\u03b2-amyloid peptide (25\u201335) and human lysozyme in the serum of patients with progressive Alzheimer's disease","volume":"18","author":"Gruden","year":"2004","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib23","doi-asserted-by":"crossref","first-page":"8876","DOI":"10.1523\/JNEUROSCI.19-20-08876.1999","article-title":"Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons","volume":"19","author":"Hartley","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib24","doi-asserted-by":"crossref","first-page":"6213","DOI":"10.1523\/JNEUROSCI.0664-05.2005","article-title":"Treatment with amyloid-beta antibodies ameliorates plague load, learning deficits and hippocampal long-term potentiation in a mouse model of Alzheimer disease","volume":"25","author":"Hartman","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib25","first-page":"1356","article-title":"S100 proteins: structure, functions and pathology","volume":"36","author":"Heizmann","year":"2002","journal-title":"Front. Biosci."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib26","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0896-6273(03)00294-0","article-title":"Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease","volume":"38","author":"Hock","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.jneuroim.2007.03.023_bib27","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1515\/REVNEURO.2005.16.3.181","article-title":"Development of beta-amyloid-induced neurodegeneration in Alzheimer's disease and novel neuroprotective strategies","volume":"16","author":"Holscher","year":"2005","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib28","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1073\/pnas.96.6.3228","article-title":"Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models","volume":"96","author":"Hsia","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib29","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1093\/brain\/awl279","article-title":"Proteome-based plasma biomarkers for Alzheimer's disease","volume":"129","author":"Hye","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2007.03.023_bib30","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nm0706-755","article-title":"Can the immune system fight Alzheimer disease?","volume":"12","author":"Hyman","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib31","first-page":"1179","article-title":"Detection in life of confirmed Alzheimer disease using a simple measurement of medial temporal lobe atrophy by computed tomography","volume":"14","author":"Jobst","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2007.03.023_bib33","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1002\/cncr.11409","article-title":"Serum S100\u03b2. A noninvasive marker of blood\u2013brain barrier function and brain lesions","volume":"97","author":"Kanner","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.jneuroim.2007.03.023_bib32","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1126\/science.1079469","article-title":"Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis","volume":"300","author":"Kayed","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jneuroim.2007.03.023_bib34","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0166-2236(00)01749-5","article-title":"Targeting small A beta oligomers and AD conundrum","volume":"24","author":"Klein","year":"2001","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib35","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0028-3932(98)00017-7","article-title":"Memory impairments associated with hippocampal versus parahippocampal\u2013gyrus atrophy: an MR volumetry study in Alzheimer's disease","volume":"36","author":"Kohler","year":"1998","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.jneuroim.2007.03.023_bib36","doi-asserted-by":"crossref","first-page":"6331","DOI":"10.1523\/JNEUROSCI.22-15-06331.2002","article-title":"Reversible memory loss in a mouse transgenic model of Alzheimer's disease","volume":"22","author":"Kotilinek","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib37","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/jnr.10391","article-title":"In vivo conversion of racemized beta amyloid ([d-Ser 26]A\u03b2 1\u201340) to truncated and toxic fragments ([d-Ser 26]A\u03b2 25\u201335\/40) and fragment presence in the brains of Alzheimer's patients","volume":"70","author":"Kubo","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib38","doi-asserted-by":"crossref","first-page":"9319","DOI":"10.1523\/JNEUROSCI.3246-05.2005","article-title":"Amyloid plaques and amyloid-beta oligomers: an ongoing debate","volume":"25","author":"Lesne","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib39","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/nature04533","article-title":"A specific amyloid-beta protein assembly in the brain impairs memory","volume":"440","author":"Lesne","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2007.03.023_bib40","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1046\/j.1471-4159.1998.71041421.x","article-title":"S100 beta increases levels of beta-amyloid precursor protein and its encoding mRNA in rat neuronal cultures","volume":"71","author":"Li","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib41","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1096\/fj.03-0770fje","article-title":"Dopamine and l-dopa disaggregate amyloid fibrils: implications for Parkinson's and Alzheimer's disease","volume":"18","author":"Li","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib42","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF03327434","article-title":"Immunological and immunogenetic markers in sporadic Alzheimer's disease","volume":"18","author":"Lio","year":"2006","journal-title":"Aging Clin. Exp. Res."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib43","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1176\/ps.48.5.634","article-title":"Movement disorders and substance abuse","volume":"48","author":"Lopez","year":"1997","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib44","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.nbd.2006.02.010","article-title":"Soluble oligomers of amyloid-beta peptide induce neuronal apoptosis by activating a cPLA2-dependent sphingomyelinase-ceramide pathway","volume":"23","author":"Malaplate-Armand","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib45","doi-asserted-by":"crossref","first-page":"6269","DOI":"10.1074\/jbc.M407273200","article-title":"Does the cytotoxic effect of transient amyloid oligomers from common equine lysozyme in vitro imply innate amyloid toxicity?","volume":"280","author":"Mali\u0161auskas","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib46","first-page":"350","article-title":"Neurotransmitters in Alzheimer's disease","volume":"42","author":"Manzano-Palomo","year":"2006","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib47","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1111\/j.1471-4159.2006.03989.x","article-title":"Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics","volume":"97","author":"Masters","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib48","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/mds.870120604","article-title":"The role of the immune system in neurodegenerative disorders","volume":"12","author":"McGeer","year":"1997","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib49","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0197-4580(01)00289-5","article-title":"Inflammation, autotoxicity and Alzheimer disease","volume":"22","author":"McGeer","year":"2001","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jneuroim.2007.03.023_bib50","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS\u2013ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2007.03.023_bib51","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","article-title":"The Clinical Dementia Rating (CDR): current version and scoring rules","volume":"43","author":"Morris","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2007.03.023_bib52","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0197-4580(01)00293-7","article-title":"The role of activated astrocytes and of the neurotrophic cytokine S100B in the pathogenesis of Alzheimer's disease","volume":"22","author":"Mrak","year":"2001","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jneuroim.2007.03.023_bib53","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1023\/A:1017527508878","article-title":"Autoantibodies to beta-amyloid and neurotransmitters in patients with Alzheimer's disease and senile dementia of the Alzheimer type","volume":"131","author":"Myagkova","year":"2001","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib54","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/jama.283.12.1571","article-title":"Correlation between elevated levels of amyloid \u03b2-peptide in the brain and cognitive decline","volume":"283","author":"Naslund","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jneuroim.2007.03.023_bib55","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1385\/NMM:3:1:29","article-title":"Autoantibodies to amyloid beta-peptide (Abeta) are increased in Alzheimer's disease neurotoxicity: implications for disease pathogenesis and vaccine development","volume":"3","author":"Nath","year":"2003","journal-title":"Neuromolecular Med."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib56","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/BF00711237","article-title":"Monoamine neurotransmitters and their metabolites in brain regions in Alzheimer's disease: a postmortem study","volume":"12","author":"Nazarali","year":"1992","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib57","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1038\/nrn1433","article-title":"Advances in the early detection of Alzheimer's disease","volume":"10","author":"Nestor","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib58","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0301-0082(02)00011-4","article-title":"Dopamine and the regulation of cognition and attention","volume":"67","author":"Nieoullon","year":"2002","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib59","first-page":"185","article-title":"Immunotherapy of Alzheimer disease","volume":"18","author":"Nitsch","year":"2004","journal-title":"Alzheimer's Disease Assoc. Disord."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib60","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1073\/pnas.022662599","article-title":"Conformational Abs recognizing a generic amyloid fibril epitope","volume":"99","author":"O'Nuallain","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib61","doi-asserted-by":"crossref","first-page":"7071","DOI":"10.4049\/jimmunol.176.11.7071","article-title":"Diagnostic and therapeutic potential of amyloid-reactive IgG antibodies contained in human Sera","volume":"176","author":"O'Nuallain","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib62","doi-asserted-by":"crossref","unstructured":"Ostrovskaya, R.U., Gruden, M.A., Bobkova, N.A., Sewell, R.D.E., Gudasheva, T.A., Samokhin, A.N., Seredinin, S.B., Noppe, W., Sherstnev, V.V., Morozova-Roche, L.A., in press. The nootropic and neuroprotective proline-containing dipeptide noopept restores spatial memory and increases immunoreactivity to amyloid in an Alzheimer's disease model. J. Psychopharm. 20, (J Psychopharmacol. 2006 Nov 8; [Electronic publication ahead of print]).","DOI":"10.1177\/0269881106071335"},{"key":"10.1016\/j.jneuroim.2007.03.023_bib63","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1126\/science.179.4080.1340","article-title":"Serotonin: radioimmunoassay","volume":"179","author":"Peskar","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.jneuroim.2007.03.023_bib64","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0197-0186(01)00048-1","article-title":"Cerebrospinal fluid S100b is elevated in the earlier stages of Alzheimer's disease","volume":"39","author":"Peskind","year":"2001","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib65","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0304-3940(02)01257-0","article-title":"Cerebrospinal fluid S100B correlates with brain atrophy in Alzheimer's disease","volume":"336","author":"Petzold","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib66","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1523\/JNEUROSCI.13-04-01676.1993","article-title":"Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state","volume":"13","author":"Pike","year":"1993","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib67","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1046\/j.1471-4159.1995.64010253.x","article-title":"Structure activity analyses of beta-amyloid peptides: contributions of the beta 25\u201335 region to aggregation and neurotoxicity","volume":"64","author":"Pike","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib69","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0197-4580(88)80061-7","article-title":"Dopaminergic system and monoamine oxidase-B activity in Alzheimer's disease","volume":"9","author":"Reinikainen","year":"1988","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jneuroim.2007.03.023_bib70","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/jnr.490270419","article-title":"Neurotransmitter changes in Alzheimer's disease: implications to diagnostics and therapy","volume":"27","author":"Reinikainen","year":"1990","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib68","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1176\/ajp.139.9.1136","article-title":"The Global Deterioration Scale for assessment of primary degenerative dementia","volume":"139","author":"Reisberg","year":"1982","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib71","series-title":"Clinical Immunology: Principles and Practice","year":"2001"},{"issue":"9347","key":"10.1016\/j.jneuroim.2007.03.023_bib72","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/S0140-6736(02)11667-9","article-title":"The dementias","volume":"360","author":"Ritchie","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2007.03.023_bib74","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/02646830500382037","article-title":"Clinical aspects of inflammation in Alzheimer's disease","volume":"17","author":"Rosenberg","year":"2005","journal-title":"Int. Rev. Psychiatry"},{"key":"10.1016\/j.jneuroim.2007.03.023_bib73","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1038\/nm1066","article-title":"Protein aggregation and neurogenerative disease","volume":"10","author":"Ross","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib75","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/jemt.10303","article-title":"S100b in brain damage and neurodegeneration","volume":"60","author":"Rothermundt","year":"2003","journal-title":"Microsc. Res. Tech."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib76","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s11910-004-0084-7","article-title":"Cognitive reserve: implications for diagnosis and prevention of Alzheimer's disease","volume":"4","author":"Scarmeas","year":"2004","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib77","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/22124","article-title":"Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse","volume":"400","author":"Schenk","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2007.03.023_bib78","first-page":"679","article-title":"Immunotherapy with beta-amyloid for Alzheimer's disease: a new frontier DNA","volume":"20","author":"Schenk","year":"2001","journal-title":"Cell Biol."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib79","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.2174\/138161206777698909","article-title":"Serotonin and human cognitive performance","volume":"12","author":"Schmitt","year":"2006","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib80","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1177\/0269881105056645","article-title":"Does the human leukaemia differentiation factor fragment HLDF6 improve memory via brain DNA and protein synthesis?","volume":"19","author":"Sewell","year":"2005","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib81","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0896-6273(91)90052-2","article-title":"The molecular pathology of Alzheimer disease","volume":"6","author":"Selkoe","year":"1991","journal-title":"Neuron"},{"key":"10.1016\/j.jneuroim.2007.03.023_bib82","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0896-6273(01)00475-5","article-title":"Clearing the brain's amyloid cobwebs","volume":"3","author":"Selkoe","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.jneuroim.2007.03.023_bib83","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1126\/science.1074069","article-title":"AD is a synaptic failure","volume":"298","author":"Selkoe","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.jneuroim.2007.03.023_bib84","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000213837","article-title":"Neuroautoimmunity: pathogenic implications for Alzheimer's disease","volume":"4","author":"Singh","year":"1997","journal-title":"Gerontology"},{"key":"10.1016\/j.jneuroim.2007.03.023_bib85","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0304-3940(95)12256-7","article-title":"Monaminergic neurotransmitters, their precursors and metabolites in brains of Alzheimer's patients","volume":"203","author":"Storga","year":"1996","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib86","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ana.410300410","article-title":"Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment","volume":"30","author":"Terry","year":"1991","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib87","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0197-4580(01)00328-1","article-title":"Biochemical markers related to Alzheimer's dementia in serum and cerebrospinal fluid","volume":"23","author":"Teunissen","year":"2002","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jneuroim.2007.03.023_bib88","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0022-1759(84)90001-2","article-title":"Immunoblotting and dot immunoblotting: current status and outlook","volume":"72","author":"Towbin","year":"1984","journal-title":"J. Immunol. Methods"},{"issue":"pt 2","key":"10.1016\/j.jneuroim.2007.03.023_bib89","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1113\/jphysiol.2005.103754","article-title":"Effects of secreted oligomers of amyloid beta-protein on hippocampal synaptic plasticity: a potent role for trimers","volume":"15, 572","author":"Townsend","year":"2006","journal-title":"J. Physiol."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib90","first-page":"463","article-title":"Blood\u2013brain barrier permeability precedes senile plaque formation in an Alzheimer disease model","volume":"10","author":"Ujiie","year":"2003","journal-title":"Microcirculation"},{"key":"10.1016\/j.jneuroim.2007.03.023_bib91","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2165\/00023210-200216070-00005","article-title":"Cholinergic nicotinic systems in Alzheimer's disease: prospects for pharmacological intervention","volume":"16","author":"Vesey","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jneuroim.2007.03.023_bib92","first-page":"181","article-title":"The clinical diagnosis of vascular dementia","volume":"5","author":"Wallin","year":"1994","journal-title":"Dementia"},{"key":"10.1016\/j.jneuroim.2007.03.023_bib93","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2174\/0929866043407174","article-title":"Oligomers in the brain: the emerging role of soluble protein aggregates in neurodegeneration","volume":"11","author":"Walsh","year":"2004","journal-title":"Protein Pept. Lett."},{"issue":"6880","key":"10.1016\/j.jneuroim.2007.03.023_bib94","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/416535a","article-title":"Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo","volume":"416","author":"Walsh","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2007.03.023_bib95","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1042\/bst0300552","article-title":"Amyloid-beta oligomers: their production, toxicity and therapeutic inhibition","volume":"30","author":"Walsh","year":"2002","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib96","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0006-8993(01)03058-X","article-title":"Soluble oligomers of beta amyloid (1\u201342) inhibit long-term potentiation but not long-term depression in rat dentate gyrus","volume":"924","author":"Wang","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib99","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1523\/JNEUROSCI.1633-03.2004","volume":"24","author":"Wang","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib97","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.drudis.2006.08.004","article-title":"Clearance of amyloid-beta in Alzheimer's disease: progress, problems and perspectives","volume":"11","author":"Wang","year":"2006","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jneuroim.2007.03.023_bib98","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1179\/016164105X49436","article-title":"Physicochemical characteristics of soluble oligomeric Abeta and their pathologic role in Alzheimer's disease","volume":"8","author":"Watson","year":"2005","journal-title":"Neurol. Res."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib100","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1523\/JNEUROSCI.22-05-01858.2002","article-title":"The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease","volume":"22","author":"Westerman","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib101","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jmb.2003.11.008","article-title":"Mapping A\u03b2 amyloid fibril secondary structure using scanning proline mutagenesis","volume":"335","author":"Williams","year":"2004","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jneuroim.2007.03.023_bib102","doi-asserted-by":"crossref","first-page":"277","DOI":"10.55782\/ane-2005-1563","article-title":"Serotoninergic impairment and aggressive behavior in Alzheimer's disease","volume":"65","author":"Zarros","year":"2005","journal-title":"Acta Neurobiol. Exp. (Wars)"},{"key":"10.1016\/j.jneuroim.2007.03.023_bib103","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/j.1471-4159.2004.02385.x","article-title":"Clearing amyloid through the blood\u2013brain barrier","volume":"89","author":"Zlokovic","year":"2004","journal-title":"J. Neurochem."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572807001129?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572807001129?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:06:24Z","timestamp":1759046784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572807001129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":103,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0165572807001129"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2007.03.023","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential neuroimmune markers to the onset of Alzheimer's disease neurodegeneration and dementia: Autoantibodies to A\u03b2(25\u201335) oligomers, S100b and neurotransmitters","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2007.03.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}